Z-1084-2026 Class II Ongoing

Recalled by Diagnostica Stago, Inc. — Parsippany, NJ

FDA device recall Z-1084-2026 was initiated by Diagnostica Stago, Inc. on Dec 15, 2025 and is designated Class II. Reason for recall: Potential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results. The recall status is ongoing. Affected quantity: 438 units.

Recall details

Product Type
Devices
Report Date
Jan 21, 2026
Initiation Date
Dec 15, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
438 units

Product description

Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the qualitative detection in plasma or serum of the anti-heparin-platelet factor 4 (PF4) antibodies generated during the type II heparin-induced thrombocytopenia (HIT type II) by ELISA.

Reason for recall

Potential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results.

Distribution pattern

Worldwide - US Nationwide distribution in the states of AL, CA, FL, GA, HI, IA, MA, MI, NJ, NV, NY, OH, TN, WI and the countries of Belgium, Canada, Denmark, Algeria, Spain, Finland, France, Great Britain, Italy, Lebanon, Saudi Arabia, Uganda.

Code information

Reference Number: 00615. UDI: (01)03607450006155(11)240531(17)260531(10)271288(241)00615. Lot Number: 271288.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1084-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1084-2026. Report a data issue: hello@regdatalab.com.